肝动脉栓塞化疗并发梗阻性黄疸的诊断与治疗  

Diagnosis and treatment of obstructive jaundice following transcatheter hepatic arterial chemoembolization for hepatic cavernous hemangioma

作　　者：刘鹏飞[1] 徐雯[2] 杨甲梅[2] 

机构地区：[1]同济大学附属同济医院肝胆外科,上海200065 [2]第二军医大学东方肝胆外科医院,上海200438

出　　处：《中华消化外科杂志》2014年第9期740-742,共3页Chinese Journal of Digestive Surgery

摘　　要：肝海绵状血管瘤是肝脏最常见的良性肿瘤,近年来接受肝动脉栓塞化疗的患者越来越多,相关的并发症、后遗症也随之增多,其中胆管损伤所致的梗阻性黄疸是严重的并发症之一.对于这类症状不典型的梗阻性黄疸有可能误诊为胆道恶性肿瘤,从而对后续处理带来难以预料的影响.同济大学附属同济医院收治2例肝动脉栓塞化疗治疗肝血管瘤后发生梗阻性黄疸患者,总结其诊断与治疗经验.Hepatic cavernous hemangioma is the most common benign tumor of liver.Hepatic artery embolism chemotherapy is one of the commonly used treatment methods,but more and more related complications and sequelae have been reported recently,including obstructive jaundice caused by damaged biliary tract.Because the symptoms are not typical,obstructive jaundice might be misdiagnosed as malignant biliary tumor,which brought troubles to subsequent treatment.In this article,the clinical data of 2 patients with obstructive jaundice following transcatheter hepatic arterial chemoembolization for hepatic cavernous hemangioma were retrospectively analyzed,and the experience in the diagnosis and treatment of this disease was summarized.

关 键 词：阻塞性黄疸 肝海绵状血管瘤 肝动脉栓塞化疗 

分 类 号：R735.7[医药卫生—肿瘤]